Cardiovascular Diabetology

official impact factor 2.72

Open Access Highly Access

Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]

The FIELD Study Investigators

Cardiovascular Diabetology 2005, 4:13 doi:10.1186/1475-2840-4-13

Accesses  

  • Last 30 days: 151 accesses
  • Last 365 days: 1484 accesses
  • All time: 17300 accesses

Cited by

BioMed Central: 1 citation

Original investigation   Open Access

Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial

Russell Scott, Mark Donoghoe, Gerald F Watts, Richard O'Brien, Christopher Pardy, Marja-Riitta Taskinen, Timothy ME Davis, Peter G Colman, Patrick Manning, Gregory Fulcher, Anthony C Keech, Cardiovascular Diabetology 2011, 10:102 (21 November 2011)